Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Advocates claim Gilead and others unfairly limited competition for HIV combination pills.
Canadian researchers analyzed the reasons why people declined a nurse’s offer of PrEP.
It’s not just because of PrEP, which isn’t even easily available in England.
Both Truvada and Descovy are highly effective and safe for most people taking PrEP, but the newer option has more cost barriers.
Activists want the tech giant to take down similar ads with inaccurate claims about PrEP and HIV prevention.
This PrEP dosing strategy involves taking doses of Truvada only during the days surrounding sex.
Around 38,000 new HIV cases still occur each year, and more than 80% of people who could benefit from PrEP aren’t using it.
More than 50 AIDS and LGBT groups demand the tech giant remove “dangerous and misleading” PrEP ads.
The U.S. Health Department launched Ready, Set, PrEP to provide the HIV prevention med at no cost.
The courts will be the judge of that. And AIDS United welcomes the lawsuit over Truvada as HIV prevention.
New forms of treatment and PrEP and, hopefully, an at least partially effective vaccine will be key to fighting the epidemic in the 2020s.
An analysis of veterans seeking PrEP found that they often had to be extraordinarily persistent in their efforts to receive a prescription.
Rates of HIV acquisition were very low among people taking Descovy or Truvada, but Descovy had less effect on kidneys and bones.
HCV incidence in a Canadian study was lower than rates seen in some European countries.
The Food and Drug Administration approves once-daily Descovy for PrEP.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.